医学
类风湿性关节炎
Golimumab公司
甲氨蝶呤
内科学
优势比
胃肠病学
关节炎
阿达木单抗
作者
Noboru Kitamura,Hitomi Kobayashi,Yosuke Nagasawa,Kaita Sugiyama,Hiroshi Tsuzuki,Yutaka Tanikawa,Natsumi Ikumi,Yuito Okada,Yasuo Takahashi,Satoshi Asai,Naoto Tamura,Michihiro Ogasawara,Toshio Kawamoto,Ryohei Kuwatsuru,Hiromichi Tamaki,Genki Kidoguchi,Mutsuto Tateishi,Makiko Kimura,Yuichi Mochida,Kengo Harigane
标识
DOI:10.1111/1756-185x.14695
摘要
Attention should be given to RA patients with history of CVD, gastrointestinal disease, liver disease, or prior NSAIDs-use when considering MTX dose reduction to ensure benefits outweigh the risks of relapse.
科研通智能强力驱动
Strongly Powered by AbleSci AI